Cell therapy processes utilizing acoustophoresis

US11377651B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11377651-B2
Application numberUS-201815916270-A
CountryUS
Kind codeB2
Filing dateMar 8, 2018
Priority dateOct 19, 2016
Publication dateJul 5, 2022
Grant dateJul 5, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A closed and modular fluidic system composed of one or more acoustic elements and cell processing reagents. The system employs a cellular manufacturing process for producing cell and gene therapy therapeutics.

First claim

Opening claim text (preview).

The invention claimed is: 1. A system for producing a therapeutic by implementing a series of processes, the system comprising: a user interface for accepting a user input for process selection; a cell processing device for performing a process on a cell suspension to obtain a processed cell suspension; an acoustic device fluidly connected to the cell processing device with a closed connection and being configured to selectively implement a concentrate process, a washing process or an affinity selection process on the cell suspension or on the processed cell suspension, wherein the acoustic device includes an ultrasonic transducer configured to generate an acoustic wave to retain cellular material or a structure to which the cellular material is bound; a chamber in the acoustic device for receiving the cellular material or a structure to which the cellular material is bound, the ultrasonic transducer being coupled to the chamber; at least a portion of the chamber near the ultrasonic transducer being vertically oriented; a valve coupled to the chamber for controlling fluid flow into or out of the chamber; and a controller coupled to the user interface, the valve and the ultrasonic transducer and configured to control the valve and the ultrasonic transducer to implement a selected concentrate process, washing process or affinity selection process based on the user input. 2. The system of claim 1 , further comprising an angled wave acoustic device for fractionating the cellular material. 3. The system of claim 2 , wherein the angled wave acoustic device is configured to receive cellular material that is included in an apheresis product. 4. The system of claim 1 , wherein the acoustic device further comprises a recirculation path. 5. The system of claim 1 , further comprising a bag coupled to the chamber. 6. The system of claim 1 , further comprising a closed system. 7. The system of claim 1 , wherein the affinity selection process includes negative selection for TCR+cells. 8. The system of claim 1 , further comprising another acoustic device fluidly coupled to the acoustic device to form a closed end-to-end CAR T production process. 9. A cell therapy production system, comprising: a user configured to accept a user input for process selection; a number of fluidly interconnected devices that form a closed system, at least one of the devices being a cell processing device for performing a process on a cell suspension to obtain a processed cell suspension, and at least another one of the devices being an acoustic device configured to retain cells or structures for supporting cells in the cell suspension or in the processed cell suspension; the acoustic device including an ultrasonic transducer coupled to a vertically oriented chamber through which the cell suspension or the processed cell suspension is flowed; and a controller coupled to the user interface and the acoustic device and configured to control the acoustic device to implement a concentrate process, a washing process or an affinity selection process based on the user input. 10. The system of claim 9 , wherein the devices form and end-to-end cell therapy production system.

Assignees

Inventors

Classifications

  • C12N13/00Primary

    Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves · CPC title

  • Bags · CPC title

  • Cell isolation or sorting (purging biological preparations of unwanted cells C12N5/0081, determining the presence or kind of microorganism C12Q1/04) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11377651B2 cover?
A closed and modular fluidic system composed of one or more acoustic elements and cell processing reagents. The system employs a cellular manufacturing process for producing cell and gene therapy therapeutics.
Who is the assignee on this patent?
Flodesign Sonics Inc
What technology area does this patent fall under?
Primary CPC classification C12N13/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).